Tag

Ocella Archives - Carey Danis & Lowe

Australian Women File Yaz Lawsuits

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz-lawsuit-settlements-yasmin-lawsuit-settlementsHow can you make the right decision without proper direction? Many women have asked themselves that question after their life-changing experiences using Yaz, Yasmin, or Ocella. These women suffered serious Yaz side effects, such as a heart attack, stroke, deep vein thrombosis, or pulmonary embolism. And they’ve survived to share their stories, and to fight for their day in court.

These women want the maker of Yaz, Yasmin, and Ocella to be held responsible for a failure to warn health care providers and patients about the serious risks of using these contraceptive pills.

An article recently published by The Age, an Australian news agency, shared the experience of Amy Walker. Described as a healthy mother of three, Walker suffered a stroke―with only her young daughters present to help with contacting emergency responders.

This was a traumatic experience for the entire family.

According to Walker, the recovery period was taxing. The Age article stated that Walker “spent…the next few months unable to drive, cook or adequately care for her daughters.”

Experiences like these have pushed women to seek legal action. More than 1,000 Australian women, Walker included, have joined a Yaz class action lawsuit targeted at Bayer.

If you suffered from a Yaz heart attack, stroke, or blood clot, understand that you are not alone. There are women across the world who have been similarly impacted, and who are fighting to hold responsible the pharmaceutical giant behind Yaz. And the same goes for Yasmin and Ocella.

We are a law firm that is currently investigating Yaz, Yasmin, and Ocella cases. Carey Danis & Lowe offers free case evaluations, during which one of our experienced Yaz lawyers can walk you through your legal options, and whether filing a Yaz lawsuit is the right decision for you.

You can contact our law offices by phone at 800.721.2519, or by completing a confidential personal injury claim form here: https://www.careydanis.com/contact/.

 

You may also be interested in reading:

Australian Women Considering Yaz Class Action Lawsuit

Yaz Litigation Update: $1.8 Billion Yaz Settlement

Ontario Yaz & Yasmin Class Action Lawsuit Approved

Ontario Yaz & Yasmin Class Action Lawsuit Approved

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_bayer_multidistrict_litigation_yaz_settlements_yaz_yasmin_lawsuit_settlementsThe Ontario Superior Court of Justice has approved a Yaz and Yasmin class action lawsuit. The lawsuit includes all women residing in Ontario and Quebec who used Yaz and/or Yasmin from 2004 – 2011.

The unique aspect of this class action lawsuit is that it automatically includes Yaz and Yasmin users, regardless of whether or not they have formally requested inclusion in the case. The legal representatives of the plaintiffs have posted information about how to opt-out of the case. If a woman prefers to opt-out, she must do so before February 9, 2015.

This Yaz and Yasmin class action lawsuit targets the drugs’ manufacturer, Bayer, and centers around injuries suffered by plaintiffs. These Yaz and Yasmin injuries include blood clots, pulmonary embolism, deep vein thrombosis, gallbladder disease, and stroke. The Canadian case alleges that Bayer was aware of the risks associated with both of their contraceptive drugs, but failed to give proper warning to health care providers and patients regarding these serious side effects.

Similar suits have been filed in the U.S. by Carey Danis & Lowe on behalf of women whose lives have been forever changed by these two contraceptive drugs, as well as by the generic version, Ocella.

No-Obligation Case Evaluations

The defective drug lawyers at Carey Danis & Lowe currently represent women in Yaz and Yasmin lawsuits. Our lawyers understand the pain and suffering that these defective drugs have caused, not only to the women who have used them, but also to their families. That is why our law firm works tirelessly to recover losses for our clients.

When you seek the expert legal assistance of Carey Danis & Lowe, you can trust in our dedication to resolving your case with the best possible outcome for you and your family.

Share your Yaz, Yasmin, and Ocella story with Carey Danis & Lowe today. We offer free, no-obligation case evaluations during which we will advise you on how to move forward with your case. Contact our law offices by phone at 800.721.2519, or by submitting a confidential personal injury claim form today.

Choose today to begin standing up against negligent pharmaceutical companies. Carey Danis & Lowe is always here to help.

Yaz & Yasmin Lawsuit Update: Israeli Women & Yasmin Lawsuits

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

bayerIsraeli women who have suffered injuries, such as blood clots and pulmonary embolism, from the use of the birth control pill Yasmin are standing up against Bayer. These women have applied to file a Yasmin class action lawsuit against the drug’s manufacturer, Bayer.

According to Israeli newspaper, Haaretz, the class action lawsuit calls for compensation in the amount of NIS 204 million, which is over $53 million USD. The women involved in the Yasmin lawsuit claim that Bayer was negligent in warning patients and healthcare providers about the risks associated with use of the birth control pill.

In fact, the Haaretz article goes on to explain that the proposed suit alleges that Bayer was aware of the blood clot risk, but failed to provide sufficient update.

Bayer did eventually distribute safety information for Yasmin that included details on the blood clot risk. However, as the updated information only appeared in a safety pamphlet, this distribution method was insufficient in spreading the word on such a deadly Yasmin side effect, according to the women involved in the lawsuit.

One of the women involved in the case, Ruth Teitler, used Yasmin, and then suffered a pulmonary embolism. She told Haaretz that, after a year of using Yasmin, she experienced chest pain and trouble breathing to such a degree that she went to the hospital.

Once there, x-rays revealed that her lungs were overrun with blood clots.

Seek Legal Assistance for Your Injuries

Carey Danis & Lowe is an experienced personal injury law firm that currently represents women who have been injured by Yasmin, as well as Yaz and Ocella. We are here to help you recover losses for all of your pain and suffering from Yasmin, Yaz, or Ocella.

Contact Carey Danis & Lowe today, and share your Yasmin, Yaz, or Ocella story with us. You can reach our law offices by phone at 800.721.2519, or by completing a personal injury claim form.

We look forward to assisting you in any way that we can.

Reports Show Decline in Yaz Sales

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuitIn a recent financial report, Bayer, the pharmaceutical company behind the controversial contraceptive drug Yaz, published information showing that Yaz sales have been on the decline. According to Bayer’s report released in late July 2014, sales of Yaz have seen a significant drop when comparing the second quarter of 2013 to that of 2014.

Yaz sales brought in $250 million for Bayer in the second quarter of 2013, but only $191 million in the same quarter of 2014.

This sales decline may be related to the thousands of Yaz lawsuits that have been filed across the United States.

Also in their quarter two report is information on their $1.8 billion Yaz settlement.

Carey Danis & Lowe Represents Yaz Victims

Carey Danis & Lowe is a St. Louis law firm with highly-skilled lawyers committed to building strong cases that deliver compensation packages for our clients. Our personal injury lawyers are currently accepting Yaz, Yasmin, and Ocella cases.

If you or someone you love has been injured by Yaz, Yasmin, or Ocella, we encourage you to review your legal options and compensation eligibility with one of our lawyers today during a free initial case evaluation.

Share your Yaz story with Carey Danis & Lowe by calling 800.721.2519, or by completing a confidential personal injury claim form. We look forward to representing you.

Yaz Litigation Update: $1.8 Billion Yaz Settlement

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuitThe manufacturer of the ill-reputed contraceptive drug Yaz released a quarterly report in July that highlighted current Yaz and Yasmin litigation. According to Bayer’s report, there are around 5,000 Yaz and Yasmin lawsuits pending in the United States. In addition, Bayer reported that they arrived at a settlement agreement in early July 2014 that would affect nearly 9,000 lawsuits.

The settlement amount is for $1.8 billion. Under this particular Yaz settlement, only those cases involving venous thromboembolism, or the formation of blood clots, qualify to be considered for compensation.

Yaz & Blood Clots

Yaz and Yasmin, and the generic alternative, Ocella, have all gained the reputation of causing serious health complications, among them blood clots. Yaz, Yasmin, and Ocella contain a hormone called drospirenone which has been connected to an increased risk in the formation of blood clots.

Carey Danis & Lowe Represents Yaz Victims

Carey Danis & Lowe is a St. Louis law firm that provides expert legal representation to victims in defective drug litigation. Our attorneys are currently representing victims of Yaz, Yasmin, and Ocella, and are accepting cases.

If you or someone you love has been injured by Yaz, Yasmin, or Ocella, Carey Danis & Lowe encourages you to evaluate your options and compensation eligibility with us today in a free legal consultation.

Share your Yaz story with Carey Danis & Lowe today. We are available to listen to you. Call our law firm at 800.721.2519, or contact us by submitting a confidential personal injury claim form.

UK Doctors Warn Patients of Yasmin & Yaz Side Effects

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_yasmin_side_effects_lawsuits_dvt_blood_clot_settlementsAn article recently published by UK news organization the Daily Mail describes the country’s increased efforts in requiring physicians to adequately warn patients of the risks of using certain kinds of oral contraceptives. The article specifically mentions the oral contraceptive drug, Yasmin, which is manufactured by Bayer, the pharmaceutical company behind Yaz.

Health officials in the UK announced their new initiative amid reports that newer types of oral contraceptives place women at two times the risk of developing blood clots.

Both Yasmin and Yaz contain a newer type of synthetic hormone, what is called a third-generation progestin. A number of these third-generation progestins have been linked to an increased risk in the development of blood clots. Drospirenone, the type of progestin present in both Yasmin and Yaz, as well as generic counterpart Ocella, is just such a progestin that has been linked through numerous studies to a higher risk of venous thromboembolism.

The personal injury and defective drug lawyers at Carey Danis & Lowe are encouraged to see health officials in the United Kingdom act on the serious threats posed by Yasmin and Yaz to patient health and safety.

Carey Danis & Lowe represents victims of Yasmin and Yaz across the United States. If you believe that you have been injured by Yasmin or Yaz, we welcome you to begin exploring your legal options and eligibility for compensation today with a Carey Danis & Lowe attorney. Our initial case evaluations are free.

Carey Danis & Lowe is available to listen to your story today. Share with us how Yasmin or Yaz has impacted your health and quality of life. Contact Carey Danis & Lowe by phone at 800.721.2519, or complete one of our confidential personal injury claim forms.

Australian Women Considering Yaz Class Action Lawsuit

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_bayer_multidistrict_litigation_yaz_settlements_yaz_yasmin_lawsuit_settlementsHundreds of women in Australia are considering filing a class action lawsuit targeted at Bayer, the pharmaceutical company behind the contraceptive pills Yaz and Yasmin. The latest reports estimate that the class action lawsuit could involve 600 women.

As cited in the article from Australia’s 7 News, the British Medical Journal published studies, including one from 2011, whose data demonstrated a three fold increased risk of blood clots in women using Yaz, Yasmin, and Ocella, the generic equivalent of Yaz, in comparison to those women using other kinds of contraceptive drugs.

Many of the women who are considering filing a Yaz lawsuit against Bayer have experienced serious side effects, some of which became so serious, hospitalization was necessary. One such victim, an Australian woman interviewed for the 7 News article, experienced a stroke that she believes is the result of having used Yaz.

The woman is considering legal action for the purposes of discontinuing the manufacture of drugs like Yaz, Yasmin, and Ocella. An additional motivating factor is to prevent other women from experiencing a Yaz related stroke.

The St. Louis class action attorneys at Carey Danis & Lowe represent individuals in lawsuits filed across the United States who have been negatively affected by defective drugs. We work diligently for our clients to win them the day in court they they so rightfully deserve. Contact our experienced trial lawyers today to explore your legal options and compensation eligibility if you believe that you have sustained a serious injury as the result of using either Yaz, Yasmin, or Ocella.

Carey Danis & Lowe is ready to work with you. Share your Yaz, Yasmin, or Ocella story with us today. Contact Carey Danis & Lowe by phone at 800.721.2519, or complete a confidential personal injury claim form.

Yaz Lawsuit News: Discovery Deadline Extended in New Jersey Yaz MCL

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_settlements_mcl_mdl_multidistrict_litigation_yasmin_ocella_lawsuitsIn the Yaz, Yasmin, and Ocella multicounty litigation (MCL) in the Superior Court of New Jersey in Bergen County, the court filed a new case management order in mid-October. The court document concerns an extension of the discovery deadline, in addition to the next case management conference, which will be on November 21, 2013. The Yaz MCL is being heard by Judge Brian R. Martinotti.

MCLs like multidistrict litigations (MDLs) are created for efficiency. However, delaying the discovery process in order to build a stronger case, via the gathering of more evidence, means that both parties will be better prepared when it comes time for the bellwether trial process. This is a smart move on the part of the court, as having a dearth of evidence in the first bellwether trials could delay the legal process further.

Even so, the case management order does not reveal the reason for extending the deadline beyond the original date of December 31, 2013 to June 30, 2014.

As of late October, there are 390 cases pending in the Yaz MCL in New Jersey.

Yaz attorneys at Carey Danis & Lowe continue to hear from women who have experienced adverse side effects after using Yaz. In April 2012, the U.S. Food and Drug Administration (FDA) released a safety announcement in which they detail their review of recent Yaz studies looking at the link between the risk of Yaz blood clots while using an oral contraceptive like Yaz, Yasmin, or Ocella. After reviewing the data, the FDA concluded that there may be a strong link between Yaz and blood clots.

Assistance for Yaz Victims

If you are concerned about Yaz side effects, speak with one of Carey Danis & Lowe’s on-staff nurses.

Carey Danis & Lowe is currently accepting Yaz cases, so if you believe that your injuries were caused by Yaz, Yasmin, or Ocella, get in touch with one of our Yaz attorneys to discuss your compensation eligibility and to file a Yaz blood clot lawsuit.

Contact Carey Danis & Lowe today by calling 800.721.2519, or by completing a confidential personal injury claim.

Yaz Lawsuits & Injuries Profiled by Chicago Tribune

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

transvaginal_mesh_implants_lawsuit_litigation_settlements_obtapeIn a recent article on Yaz lawsuits from the Chicago Tribune, a former user of Yaz, 23 year old Maggie Yunker, described the injuries she incurred after a year of taking the oral contraceptive.

According to Yunker, her healthcare provider recommended Yaz because it was touted as being able to alleviate menstrual symptoms and improve skin health. A year later, Yunker had developed several blood clots, and ultimately endured a stroke at the age of 20.

Due to her injuries and compromised health, Yunker filed a Yaz lawsuit against Bayer Healthcare Pharmaceuticals. She received a $237,000 settlement from Bayer.

According to the Chicago Tribune, Bayer has spent $1.4 billion in settling 6,760 Yaz lawsuits.

Yaz Multidistrict Litigation

Yaz lawsuits have been consolidated into the U.S. District Court for the Southern District of Illinois. As of mid-September, there are 11,274 cases in the Yaz multidistrict litigation (MDL).

The case is In re: Yasmin and Yaz (drospirenone) marketing, sales practices, and products liability litigation MDL no. 2100. It is being heard by U.S. District Judge David R. Herndon.

Yaz Side Effects

Yaz contains the hormone drospirenone, which has been linked to heart attacks, strokes, deep vein thrombosis (DVT), pulmonary embolism, and brain hemorrhage. Drospirenone has been connected to an increase in potassium in the body, which in turn can prove injurious by increasing the risk of blood clot formation.

In order to address the mounting adverse event reports for Yaz, the U.S. Food and Drug Administration (FDA) ordered Bayer in 2012 to update the Yaz drug safety information to include a warning about the association between drospirenone-containing oral contraceptives and an increased risk of blood clot formation.

Yaz Case Evaluation & Health Advice

Carey Danis & Lowe is a national law firm that represents women who claim to have been injured while taking a drospirenone-containing oral contraceptive like Yaz, Yasmin, or Ocella. We work diligently to provide you with expert legal counsel and medical advice.

Contact Carey Danis & Lowe for a free legal evaluation of your Yaz, Yasmin, or Ocella case, and to speak with one of our medical experts. Our team strongly believes that if a pharmaceutical giant engages in negligent business practices and misleading marketing campaigns, they should be held responsible.

Share your story with us by calling 800.721.2519, or by submitting a personal injury claim form.

Yaz Lawsuit Cites Bayer’s Lack of Blood Clot Risk Warning

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_yasmin_side_effects_lawsuits_dvt_blood_clot_settlementsIn early September, a woman who suffered from a deep vein thrombosis (DVT) in her right leg two years ago filed a Yaz lawsuit. According to a recent article in The Pennsylvania Record, the plaintiff, Dana Dougherty, filed her Yaz lawsuit alleging that the hormone present in Yaz, drospirenone, led to her health problems.

The lawsuit goes on to claim that the maker of Yaz, Bayer Pharmaceuticals, put the oral contraceptive on the market neglecting to include proper warnings about the risks of blood clots, DVT, and other serious side effects.

In a warning released by the U.S. Food and Drug Administration (FDA) in April 2012, they provided information about the association between oral contraceptives that contain the hormone drospirenone, such as Yaz and Yasmin, and the increased risk of developing a blood clot. The FDA pointed out that, according to currently available information, blood clot formation has a stronger link to drospirenone oral contraceptives than oral contraceptives that contain other types of hormones.

The British Medical Journal published an oft-cited study in August 2009 about the increased risk of blood clot development in patients using different types of oral contraceptives. When looking at patients using an oral contraceptive containing drospirenone, the researchers recorded a six-fold increase in the risk of blood clot formation when compared to individuals not using an oral contraceptive.

Researchers have also reported a considerably increased risk of blood clot formation and other venous complications during the first six months of using a drospirenone-containing oral contraceptive like Yaz, Yasmin, or Ocella.

As a national law firm that represents women who claim to have been injured by the use of Yaz, Yasmin, or Ocella, Carey Danis & Lowe has provided expert legal counsel in numerous cases that cite similar claims about insufficient warning about blood clot risks.

In addition to the risk of blood clot formation, plaintiffs who have filed Yaz and Yasmin lawsuits have also linked the oral contraceptives to heart attack, stroke, brain hemorrhage, and pulmonary embolism.

Carey Danis & Lowe Yaz and Yasmin lawyers are currently taking cases. For a free legal evaluation and to speak with one of our medical experts, contact Carey Danis & Lowe today to learn about your legal options.

Share your story with Carey Danis & Lowe by calling us at 800.721.2519, or by submitting a personal injury claim form.